FDA.reportPublic FDA data

Dura mater graft, bioengineered

Definition
A sterile device made from bioengineered materials (e.g., cellulose fibres produced by microorganisms) used for the repair or replacement of the dura mater in a recipient during a neurosurgical procedure. Restoration of the dura mater maintains the integrity of the brain and spinal cord, and helps prevent leakage of the cerebrospinal fluid (CSF). This dural graft is typically overlaid on the patient's dura. It may be supplied in various sizes and shapes (e.g., square or rectangular) and may be sutured into place.
GUDID devices
11
Last updated
2026-06-04 19:44:10

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
10887587001357SyntheCelSynthes GmbHSC.400.006.01S2015-09-14
10887587001364SyntheCelSynthes GmbHSC.400.019.01S2015-09-14
10887587001371SyntheCelSynthes GmbHSC.400.025.01S2015-09-14
10887587001388SyntheCelSynthes GmbHSC.400.056.01S2015-09-14
10887587001395SyntheCelSynthes GmbHSC.400.120.01S2015-09-14
10887587076669SyntheCelSynthes GmbHSC.400.280.01S2022-05-26
H980SC40000601S0SyntheCelSYNTHES (U.S.A.) LPSC.400.006.01S2015-09-14
H980SC40001901S0SyntheCelSYNTHES (U.S.A.) LPSC.400.019.01S2015-09-14
H980SC40002501S0SyntheCelSYNTHES (U.S.A.) LPSC.400.025.01S2015-09-14
H980SC40005601S0SyntheCelSYNTHES (U.S.A.) LPSC.400.056.01S2015-09-14
H980SC40012001S0SyntheCelSYNTHES (U.S.A.) LPSC.400.120.01S2015-09-14